Scott David Priebe

Array ( [id] => 448720 [patent_doc_number] => 07250404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response' [patent_app_type] => utility [patent_app_number] => 10/202858 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23011 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250404.pdf [firstpage_image] =>[orig_patent_app_number] => 10202858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688872 [patent_doc_number] => 20030032597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Targeting nucleic acids to a cellular nucleus' [patent_app_type] => new [patent_app_number] => 10/200800 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12060 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032597.pdf [firstpage_image] =>[orig_patent_app_number] => 10200800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642138 [patent_doc_number] => 20030103939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Pseudotyped adeno-associated viruses and uses thereof' [patent_app_type] => new [patent_app_number] => 10/194421 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34568 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103939.pdf [firstpage_image] =>[orig_patent_app_number] => 10194421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 462451 [patent_doc_number] => 07238346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'High capacity recombinant adenoviral vector for treatment of hemophilia A' [patent_app_type] => utility [patent_app_number] => 10/191760 [patent_app_country] => US [patent_app_date] => 2002-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10248 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238346.pdf [firstpage_image] =>[orig_patent_app_number] => 10191760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6826483 [patent_doc_number] => 20030237105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'MGLUR5 metabotropic glutamate receptor gene disruptions, and compositions and methods related thereto' [patent_app_type] => new [patent_app_number] => 10/180919 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24183 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20030237105.pdf [firstpage_image] =>[orig_patent_app_number] => 10180919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127842 [patent_doc_number] => 20050059586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Identification of ses-3 and the uses of the same' [patent_app_type] => utility [patent_app_number] => 10/481581 [patent_app_country] => US [patent_app_date] => 2002-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4679 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059586.pdf [firstpage_image] =>[orig_patent_app_number] => 10481581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829822 [patent_doc_number] => 20030180880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Chromosome 1 gene and gene products related to alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 10/180781 [patent_app_country] => US [patent_app_date] => 2002-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23113 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180880.pdf [firstpage_image] =>[orig_patent_app_number] => 10180781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020822 [patent_doc_number] => 06887463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Methods and compositions for the treatment of defects in lipoprotein metabolism' [patent_app_type] => utility [patent_app_number] => 10/167264 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 33 [patent_no_of_words] => 16491 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887463.pdf [firstpage_image] =>[orig_patent_app_number] => 10167264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6842507 [patent_doc_number] => 20030147854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Adenovirus vectors for gene therapy' [patent_app_type] => new [patent_app_number] => 10/161539 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 32131 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147854.pdf [firstpage_image] =>[orig_patent_app_number] => 10161539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6800790 [patent_doc_number] => 20030095954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Novel method for promotion of angiogenesis' [patent_app_type] => new [patent_app_number] => 10/156135 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 7872 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20030095954.pdf [firstpage_image] =>[orig_patent_app_number] => 10156135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711041 [patent_doc_number] => 07056897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Inducible expression vectors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/152577 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 23072 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056897.pdf [firstpage_image] =>[orig_patent_app_number] => 10152577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821260 [patent_doc_number] => 20030219421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Calbindin-D28k protection against glucocorticoid induced cell death' [patent_app_type] => new [patent_app_number] => 10/155567 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15330 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219421.pdf [firstpage_image] =>[orig_patent_app_number] => 10155567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6703276 [patent_doc_number] => 20030226156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Neurodegeneration mutants, method for identifying same, and method for screening neuroprotective agents' [patent_app_type] => new [patent_app_number] => 10/154086 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12735 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20030226156.pdf [firstpage_image] =>[orig_patent_app_number] => 10154086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6111111 [patent_doc_number] => 20020172988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Nucleotide sequences' [patent_app_type] => new [patent_app_number] => 10/145949 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9109 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172988.pdf [firstpage_image] =>[orig_patent_app_number] => 10145949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 893981 [patent_doc_number] => 07341718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Neuronal gene transfer of adenovirus and herpes virus vectors' [patent_app_type] => utility [patent_app_number] => 10/476076 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6091 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341718.pdf [firstpage_image] =>[orig_patent_app_number] => 10476076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6657088 [patent_doc_number] => 20030077812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Lentiviral vectors encoding clotting factors for gene therapy' [patent_app_type] => new [patent_app_number] => 10/145289 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14110 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077812.pdf [firstpage_image] =>[orig_patent_app_number] => 10145289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725518 [patent_doc_number] => 20030207830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Mutant NDP kinases for antiviral nucleotide analog activation and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/133628 [patent_app_country] => US [patent_app_date] => 2002-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11365 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207830.pdf [firstpage_image] =>[orig_patent_app_number] => 10133628 [rel_patent_id] =>[rel_patent_doc_number] =>)